L-thyroxine
L-thyroxine is a pharmaceutical drug with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Levothyroxine Treatment on Cardiac Function in Children With Subclinical Hypothyroidism
Role of Levothyroxine Supplementation in Delayed Recovery Following Cardiac Surgery
Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism
Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism
L-Thyroxine Supplementation for Preterm Newborns Less Than 32 Weeks of Gestation With Hypothyroxinemia
Clinical Trials (7)
Levothyroxine Treatment on Cardiac Function in Children With Subclinical Hypothyroidism
Role of Levothyroxine Supplementation in Delayed Recovery Following Cardiac Surgery
Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism
Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism
L-Thyroxine Supplementation for Preterm Newborns Less Than 32 Weeks of Gestation With Hypothyroxinemia
Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression
Metabolic Changes in Hypothyroid Patients
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7